Estimations des analystes de Wall Street pour None (ALLR): objectif de cours de consensus, recommandations achat/conserver/vente et prévisions de revenus, BPA et EBITDA pour les prochains exercices.
Consensus des analystes
| Achat fort | 0 |
| Achat | 1 |
| Conserver | 1 |
| Vente | 0 |
| Vente forte | 0 |
| Analystes au total | 2 |
| Note moyenne (1-5) | 0.50 |
Compte de Résultat (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenus | $143277 | $1.5M | $1.5M | $120000 | 0 | 0 | 0 | 0 | 0 | $320000 |
| Coût des Ventes | 0 | $2.2M | $5.1M | 0 | 0 | $106000 | $120000 | 0 | 0 | 0 |
| Marge Brute | $143277 | -$761495 | -$3.6M | $120000 | 0 | -$106000 | -$120000 | 0 | 0 | $320000 |
| R&D | 0 | 0 | 0 | $6.4M | $4.2M | $14.2M | $6.9M | $7.1M | $6.1M | $6.6M |
| Frais Généraux | $272392 | $3.1M | $1.3M | $3.9M | $4.1M | $12.4M | $10.0M | $10.0M | $11.4M | $6.3M |
| Charges Opérationnelles | $4.6M | $3.1M | $1.4M | $17.7M | $8.3M | $26.6M | $34.5M | $17.1M | $27.2M | $12.9M |
| Résultat Opérationnel | -$4.5M | -$3.8M | -$5.0M | -$17.6M | -$8.3M | -$26.6M | -$34.5M | -$17.1M | -$27.2M | -$12.6M |
| EBITDA | -$4.2M | -$3.8M | -$4.9M | -$15.6M | -$6.0M | -$25.8M | -$17.3M | -$11.3M | -$24.2M | -$11.0M |
| Charges d'Intérêt | $43697 | $2417 | $233236 | $3.3M | $320000 | $640000 | $223000 | $498000 | $653000 | $185000 |
| Résultat Avant Impôts | -$4.4M | -$5.0M | -$3.5M | -$19.0M | -$6.4M | -$26.5M | -$17.6M | -$11.8M | -$24.9M | -$11.2M |
| Impôts | -$766892 | -$95086 | -$1.1M | -$4.6M | $198000 | $133000 | -$1.5M | $83000 | -$381000 | 0 |
| Résultat Net | -$3.7M | -$4.9M | -$2.3M | -$14.3M | -$6.6M | -$26.6M | -$16.1M | -$11.9M | -$24.5M | -$11.2M |
| BPA | $0.00 | $0.00 | $0.00 | $-189613.00 | $-1698639.00 | $-79074.18 | $-31799.09 | $-6031.31 | $-15.79 | $-0.78 |
| BPA Dilué | $0.00 | $0.00 | $0.00 | $-189613.00 | $-1698639.00 | $-79074.18 | $-31799.09 | $-6031.31 | $-15.79 | $-0.78 |
| Actions en Circulation (Diluées) | 0 | 0 | 0 | $75485 | $4 | $7570 | $11341 | $3.3M | $1.6M | $14.4M |
Entreprises liées: BCTX · CASI · CING · CLSD · CRIS · ENTO · KAPA
Plus de sections de ALLR: Vue d'ensemble · Financiers · Valorisation · Statistiques · Technique · Actionnariat · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions